VBI Vaccines - 25 Year Stock Price History | VBIV

Historical daily share price chart and data for VBI Vaccines since 1995 adjusted for splits. The latest closing stock price for VBI Vaccines as of April 08, 2020 is 0.95.
  • The all-time high VBI Vaccines stock closing price was 91.68 on August 02, 2005.
  • The VBI Vaccines 52-week high stock price is 2.11, which is 122.1% above the current share price.
  • The VBI Vaccines 52-week low stock price is 0.47, which is 50.5% below the current share price.
  • The average VBI Vaccines stock price for the last 52 weeks is 1.09.
VBI Vaccines Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.2649 1.3400 1.9100 0.7250 0.9465 -31.41%
2019 1.2509 1.6500 2.1200 0.4712 1.3800 -13.75%
2018 2.7983 4.4700 4.4700 1.2200 1.6000 -62.53%
2017 4.2770 3.2600 6.4600 3.1500 4.2700 37.74%
2016 3.8547 4.6200 5.0998 2.1000 3.1000 -36.48%
2015 5.4265 6.5540 6.5540 4.5400 4.8800 -26.73%
2014 7.8698 10.1000 12.7000 4.0400 6.6600 -34.06%
2013 9.5674 8.2000 17.9000 6.1000 10.1000 26.25%
2012 8.9909 6.0000 13.5000 5.6000 8.0000 50.94%
2011 10.1249 10.2000 13.0000 5.1000 5.3000 -51.38%
2010 13.1983 15.0000 16.2000 8.8000 10.9000 -31.45%
2009 13.5273 10.8000 25.1000 8.0000 15.9000 52.88%
2008 36.6861 48.7000 55.2000 10.0000 10.4000 -78.33%
2007 50.8385 50.6000 60.5000 43.5000 48.0000 -7.69%
2006 62.3355 60.0000 86.1000 47.8000 52.0000 -13.12%
2005 53.0885 41.5050 91.6800 38.2500 59.8500 44.22%
2004 40.1064 50.0000 76.5000 26.1000 41.5000 -9.49%
2003 28.4022 23.2500 52.3500 20.1000 45.8500 97.20%
2002 30.5246 35.5000 41.1500 23.0550 23.2500 -31.11%
2001 26.0372 25.7800 33.7500 20.6250 33.7500 30.92%
2000 34.6685 26.2500 45.0000 25.3000 25.7800 -4.16%
1999 21.8001 13.1250 27.5000 13.1250 26.9000 38.84%
1998 19.0222 25.6250 33.7500 10.0000 19.3750 -26.19%
1997 19.6668 13.7500 33.1250 12.8150 26.2500 90.91%
1996 10.4947 5.0000 17.5000 4.3750 13.7500 175.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.167B $0.002B
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.140B 14.08
Gilead Sciences (GILD) United States $94.011B 12.16
CSL (CSLLY) Australia $87.295B 0.00
Vertex Pharmaceuticals (VRTX) United States $64.213B 58.28
Regeneron Pharmaceuticals (REGN) United States $55.175B 23.37
Biogen (BIIB) United States $52.430B 8.95
Illumina (ILMN) United States $41.254B 42.65
Alexion Pharmaceuticals (ALXN) United States $21.037B 9.75
Seattle Genetics (SGEN) United States $21.018B 0.00
Incyte (INCY) United States $18.786B 40.31
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.363B 614.08
Genmab (GMAB) Denmark $13.679B 10.62
Genmab (GNMSF) Denmark $13.202B 42.46
Galapagos (GLPG) Belgium $12.563B 38.39
Alnylam Pharmaceuticals (ALNY) United States $12.384B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.934B 51.10
Moderna (MRNA) United States $10.535B 0.00
BioNTech SE (BNTX) Germany $10.318B 0.00
Exact Sciences (EXAS) United States $9.263B 0.00
QIAGEN (QGEN) Netherlands $9.158B 27.92
BeiGene (BGNE) Cayman Islands $8.861B 0.00
Sarepta Therapeutics (SRPT) United States $7.776B 0.00
Bio-Techne Corp (TECH) United States $7.425B 50.82
ACADIA Pharmaceuticals (ACAD) United States $6.479B 0.00
Guardant Health (GH) United States $6.039B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.902B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.849B 15.46
Ascendis Pharma (ASND) Denmark $5.815B 0.00
Exelixis (EXEL) United States $5.378B 17.26
Repligen (RGEN) United States $5.034B 92.05
Acceleron Pharma (XLRN) United States $4.560B 0.00
Reata Pharmaceuticals (RETA) United States $4.474B 0.00
Immunomedics (IMMU) United States $4.045B 0.00
China Biologic Products (CBPO) China $3.936B 23.36
Global Blood Therapeutics (GBT) United States $3.573B 0.00
Blueprint Medicines (BPMC) United States $3.526B 0.00
Vir Biotechnology (VIR) United States $3.523B 0.00
Mirati Therapeutics (MRTX) United States $3.341B 0.00
MorphoSys AG (MOR) Germany $3.232B 0.00
Adaptive Biotechnologies (ADPT) United States $3.152B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.107B 0.00
Emergent Biosolutions (EBS) United States $3.077B 21.36
Zai Lab (ZLAB) China $2.984B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.936B 0.00
NeoGenomics (NEO) United States $2.616B 113.41
Amicus Therapeutics (FOLD) United States $2.598B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.514B 42.57
Deciphera Pharmaceuticals (DCPH) United States $2.422B 0.00
Arena Pharmaceuticals (ARNA) United States $2.352B 6.13
Alkermes (ALKS) Ireland $2.346B 185.88
Bluebird Bio (BLUE) United States $2.343B 0.00
Halozyme Therapeutics (HALO) United States $2.302B 0.00
UniQure (QURE) Netherlands $2.234B 0.00
MyoKardia (MYOK) United States $2.198B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.067B 0.00
Principia Biopharma (PRNB) United States $1.909B 0.00
Denali Therapeutics (DNLI) United States $1.863B 0.00
Fate Therapeutics (FATE) United States $1.836B 0.00
Amarin (AMRN) Ireland $1.800B 0.00
Alector (ALEC) United States $1.798B 0.00
Zymeworks (ZYME) Canada $1.626B 0.00
Eidos Therapeutics (EIDX) United States $1.616B 0.00
Arvinas (ARVN) United States $1.608B 0.00
Insmed (INSM) United States $1.591B 0.00
Viela Bio (VIE) United States $1.525B 0.00
Epizyme (EPZM) United States $1.517B 0.00
Akcea Therapeutics (AKCA) United States $1.503B 32.33
Dicerna Pharmaceuticals (DRNA) United States $1.335B 0.00
Ligand Pharmaceuticals (LGND) United States $1.291B 40.12
Inovio Pharmaceuticals (INO) United States $1.206B 0.00
Editas Medicine (EDIT) United States $1.159B 0.00
Coherus BioSciences (CHRS) United States $1.138B 13.55
Zealand Pharma (ZEAL) Denmark $1.130B 0.00
REGENXBIO (RGNX) United States $1.109B 0.00
Myriad Genetics (MYGN) United States $1.103B 19.46
PHARMA MAR SA (PHMMF) Spain $1.062B 0.00
NGM Biopharmaceuticals (NGM) United States $0.961B 0.00
Twist Bioscience (TWST) United States $0.936B 0.00
NextCure (NXTC) United States $0.928B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.855B 0.00
Intra-Cellular Therapies (ITCI) United States $0.847B 0.00
Beam Therapeutics (BEAM) United States $0.812B 0.00
Sangamo Therapeutics (SGMO) United States $0.789B 0.00
Adverum Biotechnologies (ADVM) United States $0.786B 0.00
Novavax (NVAX) United States $0.768B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.761B 0.00
I-Mab (IMAB) China $0.742B 0.00
Cytokineticsorporated (CYTK) United States $0.722B 0.00
Athenex (ATNX) United States $0.665B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Arcus Biosciences (RCUS) United States $0.663B 0.00
Retrophin (RTRX) United States $0.652B 0.00
GENFIT S.A (GNFT) France $0.627B 0.00
Cara Therapeutics (CARA) United States $0.624B 0.00
Bellus Health (BLU) Canada $0.615B 0.00
Mesoblast (MESO) Australia $0.601B 0.00
Kadmon Holdings (KDMN) United States $0.596B 0.00
Codexis (CDXS) United States $0.596B 0.00
Intellia Therapeutics (NTLA) United States $0.582B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.569B 5.00
Compugen (CGEN) Israel $0.566B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.547B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.537B 0.00
ANI Pharmaceuticals (ANIP) United States $0.532B 9.59
Nabriva Therapeutics AG (NBRV) Ireland $0.530B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.529B 0.00
Castle Biosciences (CSTL) United States $0.526B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.513B 0.00
Clovis Oncology (CLVS) United States $0.499B 0.00
Frequency Therapeutics (FREQ) United States $0.473B 0.00
Athersys (ATHX) United States $0.473B 0.00
Verastem (VSTM) United States $0.463B 0.00
Intrexon (PGEN) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AC Immune SA (ACIU) Switzerland $0.460B 11.74
MeiraGTx Holdings (MGTX) United States $0.457B 0.00
Sorrento Therapeutics (SRNE) United States $0.457B 0.00
Scholar Rock Holding (SRRK) United States $0.445B 0.00
Prothena (PRTA) Ireland $0.443B 0.00
Heska (HSKA) United States $0.439B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.433B 0.00
DBV Technologies S.A (DBVT) France $0.422B 0.00
Cel-Sci (CVM) United States $0.421B 0.00
Vericel (VCEL) United States $0.420B 62.33
UROGEN PHARMA (URGN) United States $0.415B 0.00
Cue Biopharma (CUE) United States $0.401B 0.00
Morphic Holding (MORF) United States $0.400B 0.00
Anika Therapeutics (ANIK) United States $0.398B 13.71
Cellectis S.A (CLLS) France $0.386B 0.00
MiMedx (MDXG) United States $0.386B 0.00
Agenus (AGEN) United States $0.385B 0.00
AnaptysBio (ANAB) United States $0.384B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.382B 0.00
BioDelivery Sciences (BDSI) United States $0.380B 43.78
Adaptimmune Therapeutics (ADAP) United Kingdom $0.368B 0.00
CytomX Therapeutics (CTMX) United States $0.354B 0.00
Mersana Therapeutics (MRSN) United States $0.352B 0.00
PDL BioPharma (PDLI) United States $0.345B 10.33
Kala Pharmaceuticals (KALA) United States $0.328B 0.00
Merus (MRUS) Netherlands $0.319B 0.00
Pfenex (PFNX) United States $0.303B 442.00
Syros Pharmaceuticals (SYRS) United States $0.302B 0.00
Cellular Biomedicine (CBMG) United States $0.293B 0.00
Precision BioSciences (DTIL) United States $0.287B 0.00
NantKwest (NK) United States $0.281B 0.00
Puma Biotechnology (PBYI) United States $0.281B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.277B 0.00
Kamada (KMDA) Israel $0.272B 11.30
WAVE Life Sciences (WVE) Singapore $0.267B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.263B 0.00
Dynavax Technologies (DVAX) United States $0.259B 0.00
Avid Bioservices (CDMO) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.254B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.249B 0.00
Stemline Therapeutics (STML) United States $0.238B 0.00
Gritstone Oncology (GRTS) United States $0.229B 0.00
Seres Therapeutics (MCRB) United States $0.225B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.225B 0.00
Albireo Pharma (ALBO) United States $0.223B 0.00
Sutro Biopharma (STRO) United States $0.222B 0.00
MannKind (MNKD) United States $0.211B 0.00
Geron (GERN) United States $0.210B 0.00
Alcobra (ARCT) United States $0.207B 0.00
ChromaDex (CDXC) United States $0.201B 0.00
Starpharma Holdings (SPHRY) Australia $0.201B 0.00
Aduro Biotech (ADRO) United States $0.201B 0.00
Abeona Therapeutics (ABEO) United States $0.192B 0.00
XOMA (XOMA) United States $0.188B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.187B 1.68
Protagonist Therapeutics (PTGX) United States $0.177B 0.00
Prometic Life Sciences (LMNL) Canada $0.176B 0.00
HOOKIPA Pharma (HOOK) United States $0.174B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.169B 0.00
IVERIC Bio (ISEE) United States $0.162B 0.00
Selecta Biosciences (SELB) United States $0.160B 0.00
OSMOTICA PHARM (OSMT) United States $0.157B 0.00
Kindred Biosciences (KIN) United States $0.156B 0.00
Spero Therapeutics (SPRO) United States $0.153B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.151B 0.00
Dyadic (DYAI) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Fortress Biotech (FBIO) United States $0.144B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.142B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.141B 0.00
VolitionRX (VNRX) United States $0.141B 0.00
Exicure (XCUR) United States $0.140B 0.00
Aytu Bioscience (AYTU) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Affimed (AFMD) Germany $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Antibe Therapeutics (ATBPF) Canada $0.133B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
VTv Therapeutics (VTVT) United States $0.125B 0.00
Cerecor (CERC) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.124B 0.00
Theratechnologies (THTX) Canada $0.123B 0.00
Enzo Biochem (ENZ) United States $0.116B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.113B 4.45
Northwest Biotherapeutics (NWBO) United States $0.112B 0.00
Celyad SA (CYAD) Belgium $0.108B 0.00
Strongbridge Biopharma (SBBP) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.095B 0.00
Aptinyx (APTX) United States $0.094B 0.00
Palatin Technologies (PTN) United States $0.094B 2.57
TELA Bio (TELA) United States $0.091B 0.00
PHASEBIO PHARMA (PHAS) United States $0.088B 0.00
IBio (IBIO) United States $0.088B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
Five Prime Therapeutics (FPRX) United States $0.087B 0.00
CorMedix Inc (CRMD) United States $0.084B 0.00
Happiness Biotech Group (HAPP) China $0.079B 0.00
Orgenesis (ORGS) United States $0.076B 4.47
Pluristem Therapeutics (PSTI) Israel $0.073B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Arbutus Biopharma (ABUS) Canada $0.072B 0.00
Cyclerion Therapeutics (CYCN) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Eton Pharmaceuticals (ETON) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.058B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 0.00
SESEN BIO, INC (SESN) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Synlogic (SYBX) United States $0.056B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Catalyst Biosciences (CBIO) United States $0.053B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Trevena (TRVN) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Advaxis (ADXS) United States $0.037B 0.00
Protalix BioTherapeutics (PLX) Israel $0.036B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.035B 0.00
Soligenix (SNGX) United States $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
CollPlant Holdings (CLGN) Israel $0.035B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
Celsion (CLSN) United States $0.028B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Pulmatrix (PULM) United States $0.027B 0.00
OvaScience (MLND) United States $0.026B 0.00
Menlo Therapeutics (MNLO) United States $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
Curis (CRIS) United States $0.023B 0.00
TOCAGEN INC (TOCA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
BioCardia (BCDA) United States $0.020B 0.00
Alimera Sciences (ALIM) United States $0.020B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.013B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00